Yubao M. Wang

Oncology
725 Orchard Park Rd
Buffalo, NY 14224

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 29, 2026

Retraction: Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.

Retraction: Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.

Journal: The Journal of experimental medicine
Published: June 12, 2026

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026

Dual Modes of Gene Regulation by CDK12.

Dual Modes of Gene Regulation by CDK12.

Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025

Study of NSD2 using a dTAG system reveals its molecular mechanism and oncogenic implications in t(4;14) multiple myeloma.

Study of NSD2 using a dTAG system reveals its molecular mechanism and oncogenic implications in t(4;14) multiple myeloma.

Journal: Blood
Published: September 17, 2025

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Journal: Genes & development
Published: August 20, 2025

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2025

A degradable form of polyoma small T antigen reveals the high specificity of TAZ in regulating gene expression.

A degradable form of polyoma small T antigen reveals the high specificity of TAZ in regulating gene expression.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 03, 2025

A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.

A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.

Journal: Blood
Published: December 24, 2024

A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche.

A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche.

Journal: Experimental hematology & oncology
Published: October 19, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026